Home Bản tin của BIO Bionity.COM Newsletter No. 23/2010, 06/16/2010

Bionity.COM Newsletter No. 23/2010, 06/16/2010

Email In PDF.
New Products and Services
    > more
SeccoSept® - Merck´s innovative septum seal closure for dried solvents
Combines great security and flexibility with ease of use
In combination with the innovative and unique septum seal cap SeccoSept® you also benefit from reliable quality and safe handling. The septum of SeccoSept® has outstanding self-sealing properties - resulting in stable product quality and avoiding any evaporation or interaction with the solvent for your personal safety...
Real time reaction monitoring, trend analysis and spectroscopic data profiling for process development
Discover the optimal trend in your data
This is the new dimension to track chemical reactions and miscellaneous laboratory processes. LabCognition's panorama lets you easily follow, evaluate and quantify characteristic properties of laboratory reactions. The RX module provides customizable trend and kinetic 2D and 3D spectral data analysis features...
DURAN® Super Duty beakers and Erlenmeyer flasks
The perfect addition for mechanically demanding work
Due to the increased quantity of glass, the mechanical sturdiness is significantly improved compared to standard DURAN® beakers and Erlenmeyer flasks and offers the user optimum safety when working with glassware that is subject to heavy mechanical loading...
Contamination-free PCR
40.000-fold better sensitivity in pathogen detection
DNA-contamination can strongly impact PCR performance. Molzym now offers a series of DNA-free PCR reagents and polymerases enzymes for reliable and sensitive pathogen detection...
ISOLUTE® SLE+ Supported Liquid Extraction Plates
Replace expensive traditional SPE and labor intensive LLE methods
ISOLUTE® SLE+ Supported Liquid Extraction plates offer an efficient alternative to traditional liquid-liquid extraction (LLE) for bioanalytical sample preparation, extracting up to 400 µL aqueous sample. ISOLUTE SLE+ plates provide high analyte recoveries, eliminate emulsion formation, and cut sample preparation time in half...
World's smallest FT-IR spectrometer
The new ALPHA by Bruker Optik
Efficient FT-IR Analytics! With Bruker Optics' ALPHA. The implementation of the most modern technologies and the innovative user concept substantially reduce the operating costs of the ALPHA...
BRANDplates ® - the new range of microplates
A complete premium-quality line - for every application!
The new 96-, 384- and 1536-well microplates from BRAND are available in a wide variety of bottom shapes (U-/V-/F-/C-bottom) and materials (transparent, white and black). Specific surface treatment results in 8 different surface types to fulfil the needs of a broad range of cell culture-, immunology- and standard-applications...
SECURITY - FDA/GXP compliant high level security options for your spectroscopic data
Protect your knowledge! Secure your valuable data! Control your workflows
Benefit from workflow oriented data access control. Protect you knowledge and valuable spectroscopic data! Secure your data by electronic signatures and object versioning. The new Security Add-On module of well known panorama does it all......
Fast, Efficient and Competitive Pipetting with CyBi®-SELMA
Semi-automatic 96-fold pipettor with minimal required space
Applications like replication or serial dilution can be executed reproducibly and conveniently with the semi-automatic pipettor for easy and fast filling of microplates, using an intuitive touchscreen...
SDR SensorDish® Reader - Non-invasive on-line culture monitoring of oxygen and pH
The SDR SensorDish® Reader is a small 24-channel reader for non-invasive detection of oxygen and pH in disposable 24- or 6-well multidishes. The multidishes contain a sensor spot at the bottom of each well. They are read out non-invasively and non-destructively through the transparent bottom of the multidishes by the SensorDish® Reader placed below them...
 
Biotech News
    > more
Latest News from Biotechnology and Pharma from 06/09/2010 to 06/15/2010
Chemie.DE Information Service's 10th Anniversary: an Online Success Story
06/15/2010 - Ten years ago, on 15 June 2000, Chemie.DE Information Service GmbH opened for business. At a time when the DOT.COM bubble had burst and start-ups were going under in droves, four entrepreneurs took the plunge and turned a university project into a commercial company...
http://www.bionity.com/news/e/118977/
New research uncovers elusive target of antifungal agent
06/15/2010 - A research team in Japan has uncovered the mechanism underlying the antifungal activity of theonellamide (TNM), a bioactive compound found in a species of marine sponge. The finding, reported in Natur...
http://www.bionity.com/news/e/118948/
FDA advisory committee recommends approval of Novartis investigational treatment FTY720 to treat relapsing remitting MS
06/15/2010 - An advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of ...
http://www.bionity.com/news/e/118946/
Biologists isolate genes that regulate the sleep-feeding conflict
06/15/2010 - A team of biologists has isolated genes that regulate the sleep-feeding conflict. The study, which appears in Current Biology, offers new insights into how the brain chooses between behaviors that are...
http://www.bionity.com/news/e/118856/
Genzyme’s Alemtuzumab for Treatment of Multiple Sclerosis Granted Fast Track Status by FDA
06/15/2010 - Genzyme Corporation announced that its alemtuzumab for multiple sclerosis development program has been granted Fast Track status by the U.S. Food and Drug Administration (FDA). This designation covers...
http://www.bionity.com/news/e/118945/
Experts identify biological control to contain fungus killer in Kenya's maize supply
Scientists offer a natural, safe and cost-effective solution to prevent future contamination of maize by the killer aflatoxin to secure the food and income of millions of small-scale farmers in Kenya and the rest of Africa
06/15/2010 - As Kenya once again grapples with high levels of aflatoxin contamination, which has rendered at least 2.3 million bags of maize unfit for human and livestock consumption, international experts announc...
http://www.bionity.com/news/e/118858/
Silence Therapeutics Announces Issuance of Patent Covering Methods for Enhancing Silencing Activity of RNAi Therapeutics
Patent Covers Structural Modifications Associated with Innovative Zamore 'Design Rules'
06/14/2010 - Silence Therapeutics plc announced the issuance of United States patent 7,732,593, titled Methods and Compositions For Controlling Efficacy of RNA Silencing, by the United States Patent and Trademark ...
http://www.bionity.com/news/e/118850/
Researchers discover how mutations in presenilin gene cause early onset Alzheimer's disease
06/14/2010 - Researchers have discovered how mutations in the presenilin 1 gene cause early-onset Alzheimer's disease (AD). The finding, reported in Cell, opens the door to developing novel treatments for this for...
http://www.bionity.com/news/e/118855/
PANATecs awarded recertification according to ISO 9001:2008
06/14/2010 - After a recertification audit performed by the German Society for Certification of Managements Systems (DQS GmbH), PANATecs has been awarded recertification. PANATecs convinced the auditors with its a...
http://www.bionity.com/news/e/118841/
Idenix Pharmaceuticals Initiates Proof-of-Concept Study for Protease Inhibitor IDX320 in Hepatitis C Patients
06/14/2010 - Idenix Pharmaceuticals, Inc. announced that it has initiated a 3-day proof-of-concept study of IDX320, a protease inhibitor for the treatment of hepatitis C virus (HCV) infection, under a Clinical Tr...
http://www.bionity.com/news/e/118843/
PurGenesis Initiates Phase 2a Trial for the Treatment of Mild-to-Moderate Distal Ulcerative Colitis
06/14/2010 - PurGenesis Technologies, Inc., announced that it has initiated a Phase 2a clinical trial to evaluate the safety, tolerability, and efficacy of PUR0110 in patients with active mild-to-moderate distal u...
http://www.bionity.com/news/e/118847/
Fungus among us could become non-food source for biodiesel production
06/11/2010 - In the quest for alternatives to soybeans, palm, and other edible oilseed plants as sources for biodiesel production, enter an unlikely new candidate: A fungus, or mold, that produces and socks away l...
http://www.bionity.com/news/e/118778/
Plastic antibody works in first tests in living animals
06/11/2010 - Scientists are reporting the first evidence that a plastic antibody — an artificial version of the proteins produced by the body's immune system — works in the bloodstream of a living animal. The disc...
http://www.bionity.com/news/e/118779/
Aeterna Zentaris Reports Final Results of a Phase 2 Study of Perifosine in the Treatment of Colorectal Cancer
06/11/2010 - Aeterna Zentaris Inc. reported final results on the clinical activity of perifosine (KRX-0401), the Company's novel, potentially first-in-class, oral anticancer agent that inhibits Akt activation in t...
http://www.bionity.com/news/e/118777/
New economic strategy team to be charged with developing, guiding growth for Ontario bioscience industry
Health and economic prosperity of Ontarians to flourish with vigorous, commercially viable life-sciences strategy
06/11/2010 - A new economic strategy team comprising representatives of major stakeholder groups in Ontario's life-sciences sector will develop and direct a plan for robust growth and commercial viability of the p...
http://www.bionity.com/news/e/118774/
Protagen Deepens Cooperation With Bayer Schering Pharma
06/11/2010 - Protagen AG and Bayer Schering Pharma AG announced the closing of a cooperation contract for discovery of novel biomarkers in Endometriosis.
Endometriosis is a debilitating gynecological medical co...
http://www.bionity.com/news/e/118839/
Starting of the European project REBORNE aiming at bone defects regeneration using stem cells and biomaterials
06/10/2010 - Submitted by the end of 2008, the project REBORNE for 'Regenerating Bone defects using New biomedical Engineering approaches' has been accepted by the European Commission in the thematic area Health o...
http://www.bionity.com/news/e/118763/
S*BIO Completes Enrollment of Patients in Phase 2 Clinical Trials for its JAK2 Inhibitor SB1518
06/10/2010 - S*BIO Pte Ltd announced that it has completed enrollment of patients in two separate Phase 2 clinical trials for its potent and orally-active JAK2 inhibitor SB1518 at multiple clinical sites in the U....
http://www.bionity.com/news/e/118766/
Sanofi Pasteur Partners With Vivalis For The Discovery of Human Monoclonal Antibodies Against Infectious Diseases
06/10/2010 - Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced the signature with Vivalis of a commercial license and collaboration agreement for the discovery and development of fully human...
http://www.bionity.com/news/e/118739/
UCB strengthens strategic alliance with WILEX
UCB's position as a strategic investor now represents 18% of WILEX shares
06/10/2010 - UCB has acquired an additional 6.65% of shares in WILEX which increases its total holding to 18.05%. The five oncology projects which WILEX acquired from UCB in early 2009 are making good progress wit...
http://www.bionity.com/news/e/118761/
Vantia Therapeutics appoints Andrew Crockett as Chief Executive Officer
06/10/2010 - Vantia Therapeutics announced that it has appointed Andrew Crockett to the position of Chief Executive Officer (CEO).
Since joining Vantia in 2009 as Vice President of Business Development, Mr Croc...
http://www.bionity.com/news/e/118764/
UF discovery could lead to better genetic screening for diabetes
06/09/2010 - University of Florida researchers have identified a protein that affects how much insulin the body produces in people with a hereditary form of diabetes. Called maturity onset diabetes of the young, o...
http://www.bionity.com/news/e/118721/
Clariant achieves industry leading ISO 13485 milestone for medical and pharma masterbatches and compounds
06/09/2010 - Clariant Masterbatches celebrates an industry milestone with the achievement of ISO 13485 accreditation for its global production plants for masterbatches for the medical and pharma sector. Clariant i...
http://www.bionity.com/news/e/118724/
Study at ASCO shows Novartis drug Afinitor first to shrink SEGA brain tumors in children and adults with tuberous sclerosis
Phase II study shows meaningful reduction in brain tumor size in 75% of patients with subependymal giant cell astrocytomas (SEGAs) from baseline to six months
06/09/2010 - Novartis announced that results from a Phase II study show Afinitor® (everolimus) tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas (SEGA...
http://www.bionity.com/news/e/118697/
VITA 34 and Hannover Medical School start project on iPS cells
06/09/2010 - VITA 34 International AG starts a joint research project on the production of so-called induced pluripotent stem cells (iPS cells) from umbilical cord blood in cooperation with the Hannover Medical Sc...
http://www.bionity.com/news/e/118722/
Scientists begin to unravel causes of mysterious skin disease
06/09/2010 - Scientists including researchers from the University of Florida have discovered additional evidence that generalized vitiligo — a disease that typically causes patches of white skin on the face, neck ...
http://www.bionity.com/news/e/118694/
 
 
Catalogues and Brochures
    > more
HACH LANGE catalogue
Practical solutions - parameter by parameter
The HACH LANGE product range covers the complete spectrum of parameters in water analysis. From wastewater, drinking water to process water. Whether in the lab or in the field. We have the right solutions for you...
New Tosoh Bioscience GPC Brochure!
This Brochure gives you a a topical and comprehensive overview about the TSK gel®polymer GPC columns. In addition to product specifications and ordering information the catalogue includes helpful advice and application data....
 

Các bản tin

Quảng cáo

Xem nhiều nhất

Thống kê

Hiện có 2 khách Trực tuyến
mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterHôm nay190
mod_vvisit_counterHôm qua238
mod_vvisit_counterTất cả169592

Đăng nhập

Ulti Clocks content

Thời tiết

Hỗ trợ trực tuyến